Harbour BioMed

Harbour BioMed

Harbour BioMed

Harbour BioMed is a global biotechnology company discovering and developing innovative therapeutics for cancer with a focus on immunooncology.
Type
B2c
Founded
2016
Raised
$176.9M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$102,800,000
Venture capital (Series C) - 2020
OrbiMed GTJA Investment Group Sage Partners +4
€67,400,000
Venture capital (Series B) - 2020
Legend Capital Zheshang Venture Capital SK Holdings +6
Team Size
1–10
Employees
$102,800,000 Venture capital (Series C)
ChinaMoneyNetwork , DealStreetAsia , AVCJ

Chinese Biotech Startup Harbour BioMed Secures $102.8M In Series C Round – China Money Network

€67,400,000 Venture capital (Series B)
Silicon Canals - European technology news , DealStreetAsia

Harbour BioMed raises €67.4M to treat coronavirus & cancer